On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

The Food and Drug Administration (FDA) recalled Zantac in 2020, with Australia and the European Union also opting for voluntary recalls. Before the recalls, Zantac was sold by GSK, US pharma ...

A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...

Twelve days after GSK secured a key win in Florida, with a state court tossing expert testimony on the cancer-causing potential of heartburn drug Zantac (ranitidine), the British company has ...

Zantac was once a widely used medication for heartburn and stomach ulcers before concerns about potential carcinogens led to a market recall. The legal developments around ranitidine have been ...

The manufacturer, Lystn LLC, has not issued a recall, despite the Food and Drug Administration’s testing and warning. The U.S. Food and Drug Administration is cautioning pet owners that FDA ...

GSK welcomed a decision from the Delaware Supreme Court to review a lower court ruling that allowed the introduction of expert evidence in the ongoing litigation over Zantac, or ranitidine.

British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does not admit to any liability in ...